Yuanjie Zhu - Search Results

Year	Number of Results
2008	3
2009	2
2010	1
2011	3
2012	1
2014	1
2015	1
2016	1
2017	1
2018	2
2019	1
2022	6
2023	10
2024	7

1

Biphasic drug release from electrospun structures.

Zhou J, Wang P, Yu DG, Zhu Y. Zhou J, et al. Among authors: zhu y. Expert Opin Drug Deliv. 2023 May;20(5):621-640. doi: 10.1080/17425247.2023.2210834. Epub 2023 May 8. Expert Opin Drug Deliv. 2023. PMID: 37140041 Review.

2

New insight into the role of fibroblasts in the epithelial immune microenvironment in the single-cell era.

Wang L, Wang B, Kou E, Du L, Zhu Y. Wang L, et al. Among authors: zhu y. Front Immunol. 2023 Sep 22;14:1259515. doi: 10.3389/fimmu.2023.1259515. eCollection 2023. Front Immunol. 2023. PMID: 37809065 Free PMC article. Review.

3

[Role of NLRP3 inflammasomes in musculoskeletal disorders].

Ding K, Gong Y, Li X, Zhu Y, Yao L. Ding K, et al. Among authors: zhu y. Sheng Wu Gong Cheng Xue Bao. 2024 Feb 25;40(2):337-349. doi: 10.13345/j.cjb.230378. Sheng Wu Gong Cheng Xue Bao. 2024. PMID: 38369825 Free article. Review. Chinese.

4

Dual-Modal Nanoscavenger for Detoxification of Organophosphorus Compounds.

Zou S, Wang B, Wang Q, Liu G, Song J, Zhang F, Li J, Wang F, He Q, Zhu Y, Zhang L. Zou S, et al. Among authors: zhu y. ACS Appl Mater Interfaces. 2022 Sep 21;14(37):42454-42467. doi: 10.1021/acsami.2c11737. Epub 2022 Sep 11. ACS Appl Mater Interfaces. 2022. PMID: 36089739

5

Evidence-based therapies of Chinese medicine for chronic urticaria: Where do we stand and where are we going?

Wang YM, Du L, Zhu YJ. Wang YM, et al. Chin J Integr Med. 2017 Aug;23(8):566-569. doi: 10.1007/s11655-016-2533-y. Epub 2016 Nov 29. Chin J Integr Med. 2017. PMID: 27900606 Review.

6

Systemic Review of Published Reports on Primary Cutaneous Cryptococcosis in Immunocompetent Patients.

Du L, Yang Y, Gu J, Chen J, Liao W, Zhu Y. Du L, et al. Among authors: zhu y. Mycopathologia. 2015 Aug;180(1-2):19-25. doi: 10.1007/s11046-015-9880-7. Epub 2015 Mar 4. Mycopathologia. 2015. PMID: 25736173 Review.

7

Cryptococcal meningitis in immunocompetent children.

Yuanjie Z, Jianghan C, Nan X, Xiaojun W, Hai W, Wanqing L, Julin G. Yuanjie Z, et al. Mycoses. 2012 Mar;55(2):168-71. doi: 10.1111/j.1439-0507.2011.02063.x. Epub 2011 Jul 18. Mycoses. 2012. PMID: 21762212

8

Association of serum 25-hydroxyvitamin D3, fibroblast growth factor-23, and C1q/tumor necrosis factor-related protein-3 with coronary artery calcification in nondialysis chronic kidney disease patients.

Zhu Y, Hu Z, Liu Y, Qin C, Chen X, Shi Y, Wang L. Zhu Y, et al. Ren Fail. 2023 Dec;45(1):2220412. doi: 10.1080/0886022X.2023.2220412. Ren Fail. 2023. PMID: 37293793 Free PMC article.

9

Brain-targeted nanoreactors prevent the development of organophosphate-induced delayed neurological damage.

Zou S, Wang Q, He Q, Liu G, Song J, Li J, Wang F, Huang Y, Hu Y, Zhou D, Lv Y, Zhu Y, Wang B, Zhang L. Zou S, et al. Among authors: zhu y. J Nanobiotechnology. 2023 Aug 7;21(1):256. doi: 10.1186/s12951-023-02039-2. J Nanobiotechnology. 2023. PMID: 37550745 Free PMC article.

10

Combination of H1 and H2 Histamine Receptor Antagonists: Current Knowledge and Perspectives of a Classic Treatment Strategy.

Kou E, Zhang X, Dong B, Wang B, Zhu Y. Kou E, et al. Among authors: zhu y. Life (Basel). 2024 Jan 23;14(2):164. doi: 10.3390/life14020164. Life (Basel). 2024. PMID: 38398673 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

32 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Results by year